{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:45:32Z","timestamp":1791380732830,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["21ZR1457100"],"award-info":[{"award-number":["21ZR1457100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31801187"],"award-info":[{"award-number":["31801187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073013"],"award-info":[{"award-number":["82073013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113292","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:34:10Z","timestamp":1655408050000},"page":"113292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Celastrol inhibits LL37-induced rosacea by inhibiting Ca2+\/CaMKII-mTOR-NF-\u03baB activation"],"prefix":"10.1016","volume":"153","author":[{"given":"Qingyu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113292_bib1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biopha.2022.113292_bib2","article-title":"N2-Polarized Neutrophils Reduce Inflammation in Rosacea by Regulating Vascular Factors and Proliferation of CD4(+) T Cells","author":"Zhao","year":"2021","journal-title":"J. Invest Dermatol"},{"key":"10.1016\/j.biopha.2022.113292_bib3","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013560","article-title":"A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Deng","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2022.113292_bib4","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.jid.2021.02.745","article-title":"Antimicrobial peptide LL-37 drives rosacea-like skin inflammation in an NLRP3-dependent manner","volume":"141","author":"Yoon","year":"2021","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.biopha.2022.113292_bib5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","volume":"1758","author":"Durr","year":"2006","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113292_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2019.100029","article-title":"Cathelicidin LL-37: a new important molecule in the pathophysiology of systemic lupus erythematosus","volume":"3","author":"Moreno-Angarita","year":"2020","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.biopha.2022.113292_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjd.15173","article-title":"Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Schaller","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2022.113292_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003262.pub5","article-title":"Interventions for rosacea","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2022.113292_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bph.13655","article-title":"Celastrol prevents cadmium-induced neuronal cell death by blocking reactive oxygen species-mediated mammalian target of rapamycin pathway","volume":"174","author":"Zhang","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113292_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2018.00104","article-title":"Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2022.113292_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105572","article-title":"Celastrol in metabolic diseases: progress and application prospects","volume":"167","author":"Xu","year":"2021","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2022.113292_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jcp.25913","article-title":"Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1\/2 signaling in normal and neoplastic B-lymphoid cells","volume":"233","author":"Zeng","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.113292_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102171","article-title":"Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca(2+)-CaMKII-dependent PTEN\/Akt-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells","volume":"87","author":"Zeng","year":"2020","journal-title":"Cell Calcium"},{"key":"10.1016\/j.biopha.2022.113292_bib14","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/jcp.25703","article-title":"Celastrol attenuates cadmium-induced neuronal apoptosis via inhibiting Ca(2+) -CaMKII-dependent Akt\/mTOR pathway","volume":"232","author":"Zhang","year":"2017","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.113292_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106036","article-title":"Modified 5-aminolevulinic acid photodynamic therapy (M-PDT) inhibits cutaneous squamous cell carcinoma cell proliferation via targeting PP2A\/PP5-mediated MAPK signaling pathway","volume":"137","author":"Liu","year":"2021","journal-title":"Int J. Biochem Cell Biol."},{"key":"10.1016\/j.biopha.2022.113292_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.biopha.2022.113292_bib17","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.biopha.2022.113292_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cyto.2013.03.011","article-title":"hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathway","volume":"62","author":"Ke","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2022.113292_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.conb.2004.05.008","article-title":"Calcium\/calmodulin-dependent protein kinase II and synaptic plasticity","volume":"14","author":"Colbran","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.biopha.2022.113292_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113292_bib21","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent advances in understanding and managing rosacea","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.biopha.2022.113292_bib22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2022.113292_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109181","article-title":"Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea","volume":"117","author":"Yuan","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2022.113292_bib24","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/ijc.28810","article-title":"Simultaneous NF-kappaB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo","volume":"135","author":"Zheng","year":"2014","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.biopha.2022.113292_bib25","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1039\/D0TB01939A","article-title":"Current advances in the nano-delivery of celastrol for treating inflammation-associated diseases","volume":"8","author":"Fang","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2022.113292_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2019.08.026","article-title":"Celastrol-loaded PEG-PCL nanomicelles ameliorate inflammation, lipid accumulation, insulin resistance and gastrointestinal injury in diet-induced obese mice","volume":"310","author":"Zhao","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2022.113292_bib27","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1016\/j.bmc.2016.08.070","article-title":"Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties","volume":"24","author":"Jiang","year":"2016","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.biopha.2022.113292_bib28","doi-asserted-by":"crossref","first-page":"10177","DOI":"10.3390\/molecules190710177","article-title":"Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents","volume":"19","author":"Tang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.113292_bib29","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","article-title":"Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-kappaB and Notch1 pathways","volume":"20","author":"An","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2022.113292_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2022.01.018","article-title":"Celastrol attenuates psoriasiform inflammation by targeting the IRF1\/GSTM3 axis","author":"Kuai","year":"2022","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.biopha.2022.113292_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3201","article-title":"Celastrol mitigates high glucose-induced inflammation and apoptosis in rat H9c2 cardiomyocytes via miR-345-5p\/growth arrest-specific 6","volume":"22","author":"Ma","year":"2020","journal-title":"J. Gene Med"},{"key":"10.1016\/j.biopha.2022.113292_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molimm.2018.10.021","article-title":"Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway","volume":"104","author":"Zhan","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2022.113292_bib33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.apsb.2020.12.008","article-title":"Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113292_bib34","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1039\/D1BM01637G","article-title":"Biodegradable celastrol-loaded albumin nanoparticles ameliorate inflammation and lipid accumulation in diet-induced obese mice","volume":"10","author":"Fan","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2022.113292_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106178","article-title":"Hydroxychloroquine is a novel therapeutic approach for rosacea","volume":"79","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222006813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222006813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:47:17Z","timestamp":1779968837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222006813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":35,"alternative-id":["S0753332222006813"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113292","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol inhibits LL37-induced rosacea by inhibiting Ca2+\/CaMKII-mTOR-NF-\u03baB activation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113292"}}